切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (04) : 398 -405. doi: 10.3877/cma.j.issn.1674-0807.2009.04.005

临床研究

超声光散射乳腺成像诊断乳腺癌的临床价值
李越1, 赵颖1, 张斌1, 葛洁1, 宁连胜1, 曹旭晨1, 于治灏1, 王欣1,()   
  1. 1.300060 天津,天津医科大学附属肿瘤医院乳腺一科国家教育部乳腺癌防治重点实验室
  • 收稿日期:2009-04-03 出版日期:2009-08-01
  • 通信作者: 王欣

Clinical value of diffused optical tomography with ultrasound in the diagnosis of breast cancer

Yue LI1, Ying ZHAO1, Bin ZHANG1, Jie GE1, Lian-sheng NING1, Xuchen CAO1, Zhi-hao YU1, Xin WANG,1()   

  1. 1.First Department of Breast Tumor,Cancer Hospital and Institute,Tianjin Medical University,Tianjin 300060,China
  • Received:2009-04-03 Published:2009-08-01
  • Corresponding author: Xin WANG
引用本文:

李越, 赵颖, 张斌, 葛洁, 宁连胜, 曹旭晨, 于治灏, 王欣. 超声光散射乳腺成像诊断乳腺癌的临床价值[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(04): 398-405.

Yue LI, Ying ZHAO, Bin ZHANG, Jie GE, Lian-sheng NING, Xuchen CAO, Zhi-hao YU, Xin WANG. Clinical value of diffused optical tomography with ultrasound in the diagnosis of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(04): 398-405.

目的

探讨运用超声光散射乳腺成像(OPTIMUS)系统对乳腺肿块的诊断价值。

方法

回顾经病理检查证实的136例乳腺肿瘤的OPTIMUS系统表现,与病理检查结果对比分析,同时用一致性检验评价其与病理、超声、钼靶X线检查的一致性,并绘制受试者工作特征(receiver operating characteristic,ROC)曲线,计算曲线下面积(area under the curve,AUC),判断三种检查手段的准确性,评价OPTIMUS系统的临床应用价值。

结果

136例患者术后病理诊断良性病变50例,恶性病变86例。OPTIMUS系统诊断良性病变34例,恶性病变102例,其中16例被过度诊断为恶性。其与超声及钼靶X线检查的一致性检验Kappa值分别为0.536、0.386。OPTIMUS系统、超声、钼靶X线与病理检查的一致性检验Kappa值分别为0.729、0.616、0.649。OPTIMUS系统、超声及钼靶X线检查的AUC 分别为0.840(95%CI 0.764~0.916)、0.817(95%CI 0.742~0.893)及0.837(95%CI 0.771~0.902)。

结论

OPTIMUS系统对诊断乳腺恶性肿瘤的准确性及敏感性较高,可以提高乳腺癌患者的检出率,减低漏诊率。

Objective

To study the value of diffused optical breast imaging with ultrasound(OPTIMUS®,OPTIMUS system)in the diagnosis of breast tumors.

Methods

The images of 136 breast tumors by OPTIMUS system were reviewed and compared with pathological results.Meanwhile ultrasound and X-ray examinations were performed.Consistency checking was used to evaluate the consistency of pathological, ultrasound and X-ray examinations. The receiver operating characteristic(ROC)curve was done to calculate the area under the curve to evaluate the accuracy of OPTIMUS system and the clinical value of OPTIMUS system in the diagnosis of breast cancer.

Results

In the 136 cases,pathological diagnosis showed 50 cases were benign and 86 cases malignant.OPTIMUS system diagnosis showed 34 cases were benign and 102 cases malignant;among the 102 cases,16 were overdiagnosed as cancer.Bases on the pathological results,the consistency checking Kappa value was 0.536 and 0.386 for ultrasound and X-ray examinations respectively,and 0.729,0.616,and 0.649 for OPTIMUS system,ultrasound and Xray examinations respectively.The area under ROC for OPTIMUS system,ultrasound and X-ray examinations was 0.840(95%CI 0.758-0.922),0.817(95%CI 0.739-0.895)and 0.837(95%CI 0.763-0.910)respectively.

Conclusion

OPTIMUS system is a non-invasive and highly effective diagnostic tool for breast disease and it could be used as assistant diagnostic tool for breast tumors.

表1 OPTIMUS系统的BI-RADS分级
图1 浸润性导管癌的典型OPTIMUS系统图像 超声区域显示肿块边界不清,回声不均,光学图像区可见明显血流信号,患侧幅值(红色)低于健侧幅值(蓝色),患侧相位较健侧相位略有加速。这与肿瘤深度一致,血红蛋白值及含氧血红蛋白分别为0.278、0.956,BI-RADS分级为5级。
图2 腺纤维瘤的典型OPTIMUS系统图像 超声图像肿块边界清楚,回声均匀,光学图像区未见明显血流信号,患侧及健侧的幅值及相位大部分重叠,无明显恶性征象。血红蛋白值及含氧血红蛋白分别为0.128、0.826,均较恶性者为小,BI-RADS分级为2级。
图3 三种影像学检查方法诊断乳腺癌的ROC曲线
表2 OPTIMUS系统与病理检查结果的对比 (例)
表3 超声检查与病理检查结果的对比 (例)
表4 钼靶X 线与病理检查结果的对比 (例)
表5 OPTIMUS系统与超声检查结果的对比 (例)
表6 OPTIMUS系统与钼靶X线检查结果的对比 (例)
表7 OPTIMUS系统、超声、钼靶X线3种影像学诊断方法的准确性分析
[1]
罗静.新辅助化疗对早期乳腺癌保乳治疗的影响.中华乳腺病杂志: 电子版,2008,2: 34-38.
[2]
Shah N,Cerussi A,Eker C,et al.Noninvasive functional optical spectroscopy of human breast tissue.Proc Natl Acad Sci USA,2001,98: 4420-4425.
[3]
Cerussi A E,Jakubowski D,Shah N,et al.Spectroscopy enhances the information content of optical mammography.J Biomed Opt,2002,7: 60-71.
[4]
Ntziachristos V,Chance B.Probing physiology and molecular function using optical imaging: applications to breast cancer.Breast Cancer Res,2001,3: 41-46.
[5]
Tromberg B J,Shah N,Lanning R,et al.Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy.Neoplasia,2000,2: 26-40.
[6]
Strangman G,Boas D A,Sutton J P.Non-invasive neuroimaging using near-infrared light.Biol Psychiatry,2002,52: 679-693.
[7]
Mendelson E B,Baum J K,Berg W A,et al.Breast imaging reporting and data system: ultrasotmd.Reston: American College of Radiology,2003: 1-81.
[8]
刘月洁,张颖,凌广花,等.彩色多普勒超声鉴别乳腺肿物良恶性的多因素分析.中国超声医学杂志,2008,24: 119-122.
[9]
Frangioni J.New technologies for human cancer imaging.J Clin Oncol,2008,26: 4012-4021.
[10]
Zhu Q,Tannenbaum S,Kurtzman S.Optical tomograph with ultrasound localization for breast cancer diagnosis and treatment monitoring.Surg Oncol Clin N Am,2007,16: 307-321.
[11]
黄桦,陈登峰,袁璐,等.乳腺肿块微血管密度与血氧近红外光参数的实验研究.肿瘤防治研究,2007,34: 51-53.
[12]
Shah N,Cerussi A,Jakubowski D,et al.The role of diffuse optical spectroscopy in the clinical management of breast cancer.Dis Markers,2003,19: 95-105.
[13]
Zhu Q,Huang M,Chen N,et al.Ultrasound guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases.Neoplasia,2003,5: 379-388.
[14]
周景玮,陈克敏,刘林祥,等.乳腺疾病的MRI与钼靶诊断.现代医用影像学,2006,15: 280-283.
[15]
Zhou C,Choe R,Shah N,et al.Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy.J Biomed Opt,2007,12: 051903.
[16]
朱萍,王琴珠,梁长生.乳腺导管内乳头状瘤及恶变X 线诊断.中国中西医结合影像学杂志,2008,6: 148-149.
[17]
何以敉,林礼务,高上达,等.乳腺增生症超声分型与病理关系的研究.中华医学超声杂志: 电子版,2004,4: 252-255.
[18]
周晓琦,李彤,吕东梅,等.乳腺增生症的超声表现.中国实验诊断学,2004,8: 290-291.
[19]
米科睿,米素萍.几种形似乳腺实质占位性病变的声像图分析.中华医学超声杂志: 电子版,2006,3: 379.
[20]
刘中国.高频超声诊断乳腺肿块临床分析.西南军医,2005,7: 48-49.
[21]
张立花,李恩苗,陈福美,等.乳腺脂肪坏死的声像图特点及病理变化.中华医学超声杂志: 电子版,2005,2: 336.
[1] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[13] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[14] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[15] 杨爽, 余宏亮, 谢敏. CT 与超声检查对急性胰腺炎合并脂肪肝的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 541-544.
阅读次数
全文


摘要